Sage Journals: Discover world-class research

Abstract

Background and Aims: It is often the case that the genetic background of a rare disease has been solved, but the testing of a clinical patient can be performed only through research projects. Translating a research-based test into diagnostic service may also appear laborious and costly. Based on our molecular research of the genetics of Sotos syndrome, we developed a clinical laboratory test that is both effective and relatively inexpensive. Methods and Results: Pilot testing was performed with samples of clinically diagnosed Sotos cases (n=13), and testing was continued with samples of patients who were suspected of having Sotos syndrome (n=161). The testing methods used were direct sequencing and multiplex ligation-dependent probe amplification. Sotos syndrome was a suitable example for test translation, because its genetic background was well established, and the demand for the test was expected to be fairly high. In the pilot phase, a mutation was detected in 12 out of 13 patients (92%), and in the second group, 49 out of 161 (30%) patients had a mutation in the NSD1 gene. Conclusions: In Sotos syndrome, detecting the mutation is valuable for the patient/family, while the value of a negative result is less clear and other differential diagnostic diagnoses should be considered. For successful translation of the research-based test into routine diagnostics, intense collaboration between clinicians, researchers, and diagnostic laboratory personnel is essential.

Get full access to this article

View all access options for this article.

References

Cecconi

, Forzano

, Milani

et al. 2005. Mutation analysis of the NSD1 gene in a group of 59 patients with congenital overgrowth. Am J Med Genet A, 134:247-253.

Cole TRP (2005) Sotos Syndrome. Cassidy

, Allanson

. Management of Genetic Syndromes, 2nd. Hoboken: New Jersey, 527-538.

Cole

, Hughes

. 1994. Sotos syndrome: a study of the diagnostic criteria and natural history. J Med Genet, 31:20-32.

Das

, Bale

, Ledbetter

. 2008. Molecular genetic testing for ultra-rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory. Genet Med, 10:332-336.

de Boer

, Kant

, Karperien

et al. 2004. Genotype-phenotype correlation in patients suspected of having Sotos syndrome. Horm Res, 62:197-207.

Douglas

, Hanks

, Temple

et al. 2003. NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. Am J Hum Genet, 72:132-143.

Douglas

, Tatton-Brown

, Coleman

et al. 2005. Partial NSD1 deletions cause 5% of Sotos syndrome and are readily identifiable by multiplex ligation dependent probe amplification. J Med Genet, 42:e56.

Faravelli

. 2005. NSD1 mutations in Sotos syndrome. Am J Med Genet C Semin Med Genet, 137:24-31.

Faucett

, Hart

, Pagon

et al. 2008. A model program to increase translation of rare disease genetic tests: collaboration, education, and test translation program. Genet Med, 10:343-348.

10.

Grody

, Richards

. 2008. New quality assurance standards for rare disease testing. Genet Med, 10:320-324.

11.

Höglund

, Kurotaki

, Kytölä

et al. 2003. Familial Sotos syndrome is caused by a novel 1 bp deletion of the NSD1 gene. J Med Genet, 40:51-54.

12.

Javaher

, Kääriäinen

, Kristoffersson

et al. 2008. EuroGentest: DNA-based testing for heritable disorders. Community Genet, 11:71-120.

13.

Kurotaki

, Harada

, Yoshiura

et al. 2001. Molecular characterization of NSD1, a human homologue of the mouse Nsd1 gene. Gene, 279:197-204.

14.

Kurotaki

, Imaizumi

, Harada

et al. 2002. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet, 30:365-366.

15.

Leventopoulos

, Kitsiou-Tzeli

, Psoni

et al. 2009. Three novel mutations in Greek Sotos patients with rare clinical manifestations. Horm Res, 71:45-51.

16.

Nagai

, Matsumoto

, Kurotaki

et al. 2003. Sotos syndrome and haploinsufficiency of NSD1: clinical features of intragenic mutations and submicroscopic deletions. J Med Genet, 40:285-289.

17.

Piccione

, Consiglio

, Di Fiore

et al. 2011. Deletion of NSD1 exon 14 in Sotos syndrome: first description. J Genet, 90:119-123.

18.

Rio

, Clech

, Amiel

et al. 2003. Spectrum of NSD1 mutations in Sotos and Weaver syndromes. J Med Genet, 40:436-440.

19.

Saugier-Veber

, Bonnet

, Afenjar

et al. 2007. Heterogeneity of NSD1 alterations in 116 patients with Sotos syndrome. Hum Mutat, 28:1098-1107.

20.

Tatton-Brown

, Douglas

, Coleman

et al. 2005. Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet, 77:193-204.

21.

Tong

, Hau

, Lo

et al. 2005. Spectrum of NSD1 gene mutations in southern Chinese patients with Sotos syndrome. Chin Med J (Engl), 118:1499-1506.

22.

Türkmen

, Gillessen-Kaesbach

, Meinecke

et al. 2003. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes. Eur J Hum Genet, 11:858-865.

23.

Waggoner

, Raca

, Welch

et al. 2005. NSD1 analysis for Sotos syndrome: insights and perspectives from the clinical laboratory. Genet Med, 7:524-533.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

Translation of a Research-Based Genetic Test on a Rare Syndrome into Clinical Service Testing,with Sotos Syndrome As an Example

Abstract

Get full access to this article

References

Supplementary Material